Lördag 21 November | 02:43:04 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Hasko publishes prospectus and announces price for its initial public offering and listing of its B shares on Nasdaq Stockholm

2026-11-19 12:00:00

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES

On 16 November 2026, Hasko Invest AB (publ) (“Hasko”, the “Company” or the “Group”), an active and long-term owner of ambitious niche product companies in the Nordics, announced its intention to launch an initial public offering of its B shares (the “Offering”), and to list its B shares on Nasdaq Stockholm (together with the Offering, the “IPO”). Today, Hasko publishes its prospectus and announces the price in the Offering. The first day of trading is expected to be 25 November 2026. AEMG Capital Förvaltnings AB, Tredje AP-fonden, Grandeur Peak Global Advisors LLC, Amiral Gestion, Woodlock Family Capital LP and Carnegie Fonder (together, the “Cornerstone Investors”), have, subject to certain customary conditions, undertaken to acquire B shares in the Offering corresponding to a total amount of SEK 800 million.

The Offering in brief

  • The final price in the Offering is set to SEK 38 per B share (the “Offering Price”), equivalent to a valuation of approximately SEK 4.2 billion (representing the total market value of all shares in the Company after the IPO, assuming that the Offering is fully subscribed).
  • The Offering comprises 28,149,705 B shares, corresponding to approximately 25.5 percent of the shares and 12.1 percent of the total number of votes in the Company after completion of the Offering (excluding the Over-allotment Option, as defined below), of which 10,526,315 B shares are newly issued B shares in Hasko and 17,623,390 B shares are existing shares offered by Joakim Tengzelius, Carlos Lorente and Per Eriksson (together, the “Principal Shareholders”), and certain other shareholders of the Company (the “Other Selling Shareholders” and together with the Principal Shareholders, the “Selling Shareholders”).
  • The new issue of B shares is expected to provide Hasko with gross proceeds of approximately SEK 400 million before the deduction of transaction costs of approximately SEK 31 million. Hasko intends to use the net proceeds to repay part of its outstanding borrowings, as well as for general corporate purposes, which will provide the Company with strategic flexibility for future acquisitions or other investments as part of Hasko’s growth strategy. The Company will not receive any proceeds from the sale of existing shares by the Selling Shareholders.
  • Cornerstone Investors have, subject to certain customary conditions, committed to acquire, at the Offering Price, a number of B shares in the Offering corresponding to a total of SEK 800 million. The undertakings relate to 21,052,628 B shares, corresponding to 65.0 percent of the total number of B shares in the Offering (under the assumption that the Over-allotment Option is exercised in full) and 19.1 percent of the total number of shares and 9.1 percent of the total number of votes in Hasko after the Offering.
  • In connection with the IPO, the shareholders will commit, subject to certain customary exceptions, not to sell their respective holdings for a certain period (a so-called lock-up period). The lock-up period will be 720 days for the Principal Shareholders, who together will remain as Hasko’s largest shareholders after the IPO, 360 days for other members of Hasko’s management and the Board of Directors, and 180 days for Other Selling Shareholders and existing minority shareholders in the Company. In addition, the Company will undertake not to issue any new shares for a period of 360 days following the first day of trading on Nasdaq Stockholm, subject to customary exceptions, without the prior written consent of the Managers (as defined below).
  • To cover any over-allotment in connection with the Offering, Santhe Dahl Invest AB, Yarrowmena AB, NKL Invest AB, Linus Lindgren, Graciediaz AB and Batten AB will provide the Managers (as defined below) with an option entitling DNB Carnegie to, not later than 30 days from the first day of trading in the Company’s B shares on Nasdaq Stockholm, request that a maximum of 4,222,455 additional existing B shares are to be sold, corresponding to a maximum of 15 percent of the total number of B shares in the Offering (the “Over-allotment Option”), at a price corresponding to the Offering Price. The Over-allotment Option may only be exercised in order to cover any over-allotment in the Offering or short positions. Provided that the Over-allotment Option is fully exercised, the Offering will comprise 32,372,160 B shares, corresponding to approximately 29.3 percent of the shares and 14.0 percent of the votes in the Company, after the completion of the Offering.
  • Assuming that the Offering is fully subscribed, and based on the Offering Price, the total value of the Offering will amount to approximately SEK 1,070 million (approximately SEK 1,230 million if the Over-allotment Option is exercised in full).
  • The Offering is intended to be directed to the general public in Sweden and institutional investors in Sweden and abroad. The Offering to institutional investors will only be made (i) to certain institutional investors outside the United States, pursuant to Regulation S under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”); and (ii) in the United States, only to those reasonably believed to be qualified institutional buyers (”QIB”) in reliance on Rule 144A under the U.S. Securities Act.
  • The application period for the general public in Sweden and institutional investors is expected to be 20 – 24 November 2026.
  • The first day of trading on Nasdaq Stockholm is expected to be 25 November 2026 and the B shares will trade under the trading symbol (ticker) “HASKO”.
  • A prospectus (in English, with a prospectus summary in both English and Swedish), containing the complete terms and conditions for the Offering, has today been published on Hasko’s website (www.hasko.com), DNB Carnegie’s website (www.dnbcarnegie.se), Montrose’s website (www.montrose.io) and Avanza’s website (www.avanza.se).

Joakim Tengzelius, CEO and co-founder of Hasko, comments:
“We are excited to take another significant step towards the stock market, and I look forward to the next chapter in Hasko. The listing will further strengthen our position in Sweden and internationally, providing a solid foundation for the continued development of the group with a truly long-term approach. We look forward to welcoming new shareholders on this journey.”

Background and reasons for the Offering
Hasko’s founders, constituting Joakim Tengzelius, Carlos Lorente and Per Eriksson, together with the Board of Directors and the Company consider the Offering and the IPO to be a logical and important step in Hasko’s development, which will enable the Company to expand its shareholder base and to access the Swedish and international capital markets, thereby supporting Hasko’s continued growth and development and increasing the awareness of Hasko and its operations among current and potential customers, suppliers and other stakeholders. The founders Joakim Tengzelius, Per Eriksson and Carlos Lorente intend to retain a majority of their current shareholding in Hasko and will thereby remain as committed long-term shareholders and continue to contribute to the future development of the Company.

About Hasko
Hasko acquires and develops ambitious niche product companies, primarily within the Nordic region, selected for their resilience, long track record of sustainable organic growth, high profit margins and high cash conversion. Although Hasko was established in 2021, several of its Group Companies have longstanding histories within their respective markets and hold deeply rooted expertise and established reputations in their respective niches. In total, 16 of Hasko’s 17 Group Companies have a track record of more than 15 years. Since its establishment in 2021, Hasko has completed 20 acquisitions, comprising 18 primary acquisitions and two add-on acquisitions[1], of which one primary acquisition has subsequently been divested, forming its current group of 17 Group Companies across the International Products, Regional Products and Value-Added Distribution segments.

Hasko’s operating model combines active ownership with decentralised operations. Each Group Company retains its own brand, management team and operational independence following acquisition, whilst Hasko takes a supportive role, providing Group Companies with access to expertise and strategic frameworks. As an active and long-term owner, Hasko is committed to preserving the entrepreneurial culture and operational autonomy of each Group Company, whilst providing structured support and a long-term ownership perspective.

For the year ended 31 December 2025, the Group’s net sales were SEK 1,059.4 million and for the twelve months ended 30 September 2026, SEK 1,433.7 million. The companies acquired by Hasko between 1 October 2025 and 30 September 2026 generated in total SEK 167.6 million in net sales during the period from 1 October 2025 up to the date on which each such company was acquired by Hasko. For the year ended 31 December 2025, the Group’s adjusted EBITA was SEK 197.7 million and for the twelve months ended 30 September 2026, SEK 306.5 million. The companies acquired by Hasko between 1 October 2025 and 30 September 2026 generated in total SEK 47.2 million in adjusted EBITA during the period from 1 October 2025 up to the date on which each such company was acquired by Hasko. For the nine-month period ended 30 September 2026, Hasko had an organic net sales growth of 11.4 percent and organic adjusted EBITA growth of 29.0 percent.

Since its establishment, Hasko has raised approximately SEK 1.1 billion in external capital from a base of approximately 250 shareholders, which Hasko believes reflects strong investor confidence in the Group’s strategy and management team.

Hasko’s vision is to be the preferred long-term home for leading Nordic niche product companies. The Group intends to continue building on the strategy that has characterised Hasko since its establishment: acquiring high-quality niche product companies, supporting their development under a decentralised ownership model and reinvesting generated cash flow into organic initiatives and acquisitions.

Preliminary timetable

Application period for the general public in Sweden20 November – 24 November 2026
Application period for institutional investors20 November – 24 November 2026
First day of trading in Hasko’s B shares on Nasdaq Stockholm25 November 2026
Settlement date27 November 2026

Prospectus
The Company has prepared a prospectus (in English, with a prospectus summary in both English and Swedish) in connection with the Offering and the IPO. The prospectus contains the full terms and conditions for the Offering and is available on Hasko’s website (www.hasko.com), DNB Carnegie’s website (www.dnbcarnegie.se), Montrose’s website (www.montrose.io) and Avanza’s website (www.avanza.se).

The prospectus has been prepared in accordance with the Regulation (EU) 2017/1129 (the “Prospectus Regulation”). The prospectus has been approved by the Swedish Financial Supervisory Authority (the “SFSA”), which is the Swedish competent authority in accordance with the Prospectus Regulation. The SFSA only approves the prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the Prospectus Regulation. The approval should not be considered as an endorsement of the Company or support for the securities referred to in the Prospectus. The SFSA does not guarantee that the information in the Prospectus is correct or complete. Each and every investor should make their own assessment as to the suitability of investing in the Company's securities.

Stabilisation measures
In connection with the Offering, DNB Carnegie will act as stabilisation manager (the “Stabilisation Manager”) and may, to the extent permitted in accordance with Swedish law, carry out transactions aimed to stabilise, maintain, or in other ways support the market price of the Company’s B shares, for up to 30 days from the commencement of trading in the Company’s shares on Nasdaq Stockholm. The Stabilisation Manager may over-allot shares or effect transactions in order to maintain the market price of the shares at levels above those that might otherwise prevail in the open market. In no event will transactions be effected at levels above the Offering Price.

The Stabilisation Manager is, however, not required to carry out such transactions and there is no assurance that such activities will be undertaken. Such transactions may be effected on any securities market, including Nasdaq Stockholm, over-the-counter market or otherwise.

Stabilisation transactions, if commenced, may be discontinued at any time without prior notice but must be ended no later than by the end of the abovementioned 30-day period. No later than by the end of the seventh trading day after stabilisation transactions have been undertaken, it shall be made public that stabilising measures have been performed in accordance with Article 5(4) of the EU’s Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (“MAR”). Within one week of the end of the stabilisation period, the Stabilisation Manager will, through the Company, make public whether or not stabilisation was undertaken, the date at which stabilisation started, the date at which stabilisation last occurred as well as the price range within which stabilisation was carried out, for each of the dates during which stabilisation transactions were carried out. Except as required by law or regulation, neither the Managers (as defined below) nor the Stabilisation Manager will disclose the extent of any stabilisation and/or over-allotment transaction concluded in relation to the Offering.

Advisors
DNB Carnegie Investment Bank AB (publ) is acting as Sole Global Coordinator and Joint Bookrunner. Handelsbanken is acting as Joint Bookrunner. White & Case is acting as legal advisor to the Company and Schjødt is acting as legal advisor to the Sole Global Coordinator and the Joint Bookrunners.

For further information, please contact:
Joakim Tengzelius, CEO and Co-founder
E-mail: joakim@hasko.com

Erik Källmin, CFO
E-mail: erik@hasko.com

This information was submitted for publication, through the agency of the contact persons set out above, at 12:00 CET on 19 November 2026.

IMPORTANT INFORMATION
This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by Hasko Invest AB (publ) (the “Company”) in any jurisdiction where such offer or sale would be unlawful.

Any offering of the securities referred to in this announcement will be made by means of a prospectus. This announcement is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the “Prospectus Regulation”). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus.

In any EEA Member State other than Sweden, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Regulation.

This document and the information contained herein are not for distribution in or into the United States of America. This document does not constitute an offer to sell, or a solicitation of an offer to purchase, any securities in the United States. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.

In the United Kingdom, this document and any other materials in relation to the securities described herein is only being distributed to, and is only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, qualified investors (as defined in the Public Offers and Admissions to Trading Regulations 2024) and who are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “Relevant Persons”). This communication must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Persons distributing this communication must satisfy themselves that it is lawful to do so.

An investment in the Company may be subject to regulation in accordance with foreign investment control laws, which require investors, under certain conditions, to notify and obtain approval from the competent authorities. Investors should make their own assessment of whether their planned investment in the Company requires notification and approval from the competent investment control authorities under the respective investment control laws prior to making any investment decision regarding the securities.

This announcement may include statements, including the Company’s financial and operational medium- to long-term objectives that are, or may be deemed to be, "forward-looking statements". The Company has not defined, and does not intend to define, "medium-term" or "long-term". These forward-looking statements may be identified by the use of forward-looking terminology, including but not limited to the terms "aim", "anticipate", "assume", "believe", "continue", "can", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "might", "plan", "potential", "predict", "projected", "should", "will" or "would" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company’s current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company’s business, results of operations, financial position, liquidity, prospects, growth or strategies. Forward-looking statements speak only as of the date they are made. Each of the Company, the Selling Shareholders, as well as DNB Carnegie Investment Bank AB (publ) (the “Sole Global Coordinator”) and, together with Svenska Handelsbanken AB (publ) as joint bookrunner (together with the Sole Global Coordinator, the “Managers”) and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statement contained in this announcement whether as a result of new information, future developments or otherwise, unless required to do so by applicable law or the Nasdaq Stockholm Main Market Rulebook for Issuers of Shares.

None of the Managers and/or any of their respective subsidiary undertakings, affiliates or any of their respective directors, officers, employees, advisors and/or agents are responsible for the contents of this announcement.

Information to distributors
Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended (“MiFID II”); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the “MiFID II Product Governance Requirements”), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any “manufacturer” (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Company's shares subject to the Offering have been subject to a product approval process, which has determined that such shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the “Target Market Assessment”). Notwithstanding the Target Market Assessment, "distributors" (for the purposes of the MiFID II Product Governance Requirements) should note that: the price of the shares may decline and investors could lose all or part of their investment; the shares offer no guaranteed income and no capital protection; and an investment in the shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Managers will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the shares. Each distributor is responsible for undertaking its own target market assessment in respect of the shares and determining appropriate distribution channels.

[1] In addition to the add-on acquisitions referred to above, the Group Company Flexmassage AB has completed four further minor acquisitions of previously franchised clinics that have since been converted to company-owned operations, each for nominal or immaterial consideration. These are not reflected in the acquisition figures above.